Please assess the completion status of the following clinical trial:

Trial Title: Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Infants starting vaccination with 13vPnC in the first 6 months of life who are members of the Northern California Kaiser Permanente healthcase system and who receive at least 1 dose of 13vPnC during the study observation period will be included. Infants must not have had 7vPnC at the time of 13vPnC dose administration.~Exclusion Criteria:~* Infants and children who were previously vaccinated with any number of doses of 7vPnC will be excluded.

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 3 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).